Please login to the form below

acute coronary syndrome

This page shows the latest acute coronary syndrome news and features for those working in and with pharma, biotech and healthcare.

Novartis and Bayer among backers for European big data project

Its overarching aim is to improve patient outcomes and reduce the burden on society of atrial fibrillation (AF), heart failure (HF) and acute coronary syndrome (ACS).

Latest news

Another failed trial knocks back AZ's plan to grow Brilinta

Putting a brave face on the verdict, AZ's chief medical officer Sean Bohen said that the "proven benefits of Brilinta in acute coronary syndrome and post-myocardial infarction patients are
AZ's Brilinta disappoints in stroke trial

its approval in its current indication in acute coronary syndrome (ACS).
AstraZeneca wins EU approvals for Zurampic and Brilique

A 90mg dose of Brilique is already available in the EU for adults with acute coronary syndrome (ACS), but the approval of a 60mg dose means that patients with a history
Sanofi will resubmit Lyxumia for FDA approval in Q3

Although the 'Evaluation of Lixisenatide in Acute Coronary Syndrome' (ELIXA) trial failed to meet its original primary objective of demonstrating a reduction in cardiovascular morbidity and mortality, the results are still ... The type 2 diabetes study
Sanofi and Amgen poised for cholesterol drug sales

Data are due in 2017, according to Amgen. Meanwhile, Sanofi and Regeneron are carrying out the ODYSSEY OUTCOMES trial in patients with acute coronary syndrome (ACS) receiving "evidence-based medical therapy ... The primary outcome measure is a composite

More from news
Approximately 7 fully matching, plus 64 partially matching documents found.

Latest Intelligence

Why health psychology is the answer to tackling adherence

In one recent programme that we developed on behalf of AstraZeneca, we assessed the reasons for low adherence in patients with acute coronary syndrome (ACS) who had been prescribed Oral Antiplatelet

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

AZ names Brilique lead in Spain

In this role Gribble will be responsible for the company's marketing of Brilique (ticagrelor) for acute coronary syndrome, including management, development and market access activities, and he will also be ... to save the lives of thousands of people

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

Understanding the "Big Picture"

A good example would be in acute coronary syndrome (ACS) where there is data to suggest that approximately 350, 000 males in the USA currently suffer from this syndrome.
Dissecting adherence to personalise patient support

Molloy, G, et al. (2014). Intentional and unintentional non-adherence to medications following an acute coronary syndrome: a longitudinal study.

More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Medical Writer - (London, Brighton or Copenhagen): Competitive

Account Manager – Med Comms – London: Salary TBC

Head of Operations/ BUD, Healthcare PR, London – Excellent leade...: Excellent Package

Senior Account Manager / Account Director: Great salary and bebefits

Senior Medical Writer, Medical Communications, Relocate to Cardi...: Excellent Salary

Medical Writer, e-learning/ training, London: Excellent Salary

Editor – Medical Education Agency – Bucks: Salary TBC

Senior Account Manager – Med Comms – Kent: Salary TBC

Senior Medical Writer: Great salary and bebefits

Editor > Senior Editor – Medical Education – London: Very competitive with excellent benefits

Senior / Principal Regulatory Writer – Home Working - UK or US: HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

FREELANCE Account Manager – Creative Healthcare Advertising – Lo...: SUPERB DAY RATES AVAILABLE

Digital Senior Account Director – Healthcare Advertising – Londo...: Salary TBC

Principal Medical Writer, Medical Communications, Relocate to Ca...: Excellent Salary

Account Manager, Healthcare PR: £40, 000 – £42, 000 great benefits and bonuses

Editorial Team Leader or Scientific Director: £50, 000 - £55, 000 benefits

Senior Medical Writer: Great salary and benefits

FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...: EXCELLENT DAY RATES AVAILABLE

Project Manager, Medical Communications, Oxford: Excellent Salary

Engagement Strategist, Healthcare Brand Communications, London, ...: Circa £60K

Scientific Director: Great salary and bebefits

Senior Account Manager or AD - Medical Communications: Salary TBC

HOME BASED Senior Account Executive / Account Manager - Medical ...: Salary TBC

Senior Programme Executive: Salary TBC

Subscribe to our email news alerts

No results were found

PMHub

Add my company

WCG

WCG is an independent, global agency specialising in healthcare communications. Our value as a company is about being the positive...

Latest intelligence

The threat of antimicrobial resistance: Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies: Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation: HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...